IA Carboplatin + IA Caelyx for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Apr 2024: Trial registered, NCT06356883

The trials

NCT06356883: Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

State
Under way
Phase
Phase 2
People
120 planned
Started
Aug 2025
Primary completion
Apr 2027
Arms
IA Carboplatin + IA Caelyx
Results
None posted
  1. 10 Apr 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.